| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.4 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.054 | 0.4 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |